US Patent 9862767 Therapeutic methods using anti-CD200 antibodies
Patent 9862767 was granted and assigned to Alexion Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9862767 Therapeutic methods using anti-CD200 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
